SPDR S&P Pharmaceuticals ETF
XPH
XPH
71 hedge funds and large institutions have $105M invested in SPDR S&P Pharmaceuticals ETF in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 69 → 71 (+2)
100% less call options, than puts
Call options by funds: $3K | Put options by funds: $853K
Holders
71
Holding in Top 10
–
Calls
$3K
Puts
$853K
Top Buyers
| 1 | +$17M | |
| 2 | +$6.51M | |
| 3 | +$4.71M | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$3.76M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$3.32M |
Top Sellers
| 1 | -$19.1M | |
| 2 | -$1.34M | |
| 3 | -$1.31M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$802K |
| 5 |
Jane Street
New York
|
-$553K |